MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-22-2026
Johnson & Johnson Depreciation & Amortization 2011-2026 | JNJ
Annual Depreciation & Amortization Johnson & Johnson
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.5 B | 7.34 B | 7.49 B | 7.39 B | 7.23 B | - | 7.01 B | 6.93 B | 5.64 B | 3.75 B | - | 3.9 B | 4.1 B | 3.67 B | 2.94 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.5 B | 2.94 B | 5.76 B |
Quarterly Depreciation & Amortization Johnson & Johnson
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 B | 1 B | 1.3 B | 1.77 B | 1.2 B | 1.1 B | 1.82 B | 1.1 B | 1.1 B | 1.88 B | - | 1 B | 1.1 B | 1.77 B | - | 5.55 B | 1.2 B | 1.89 B | - | 5.29 B | 3.47 B | 1.75 B | - | 5.19 B | 3.47 B | 1.76 B | - | 5.19 B | 3.46 B | 1.75 B | - | 3.77 B | 2.06 B | 912 M | - | 2.7 B | 1.79 B | 891 M | - | 2.71 B | 1.78 B | 895 M | - | 2.9 B | 1.96 B | 1.01 B | - | 3 B | 2.03 B | 1.04 B | - | 2.63 B | 1.62 B | 773 M | - | 2.32 B | 1.53 B | 755 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.55 B | 755 M | 2.11 B |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
24.9 M | $ 9.13 | -0.76 % | $ 591 M |  USA |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M |  China |
 |
Aptorum Group Limited
APM
|
1.13 M | $ 0.91 | 2.42 % | $ 6.69 M | China |
 |
Edesa Biotech
EDSA
|
186 K | $ 15.52 | -2.39 % | $ 49.6 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
920 K | $ 22.47 | 1.19 % | $ 3.72 B | USA |
 |
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | USA |
 |
Fortress Biotech
FBIO
|
403 K | $ 2.24 | 0.9 % | $ 62.5 M | USA |
 |
Galectin Therapeutics
GALT
|
1 K | $ 2.26 | 0.22 % | $ 144 M | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
Harmony Biosciences Holdings
HRMY
|
23.8 M | $ 31.01 | -0.13 % | $ 1.78 B | USA |
 |
ImmuCell Corporation
ICCC
|
2.78 M | $ 8.44 | - | $ 76.2 M | USA |
 |
Incyte Corporation
INCY
|
93.3 M | $ 98.87 | -0.23 % | $ 19.3 B | USA |
 |
InMed Pharmaceuticals
INM
|
202 K | $ 0.71 | 1.28 % | $ 1.74 M |  Canada |
 |
INmune Bio
INMB
|
84 K | $ 1.35 | 1.5 % | $ 33.4 M | USA |
 |
Innoviva
INVA
|
26.3 M | $ 23.13 | 0.35 % | $ 1.56 B | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
199 K | - | -2.5 % | $ 5.88 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Jaguar Health
JAGX
|
1.91 M | $ 7.55 | -4.13 % | $ 17.6 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
969 K | $ 26.67 | -0.02 % | $ 1.44 B |  Britain |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
35.2 M | $ 223.98 | -0.39 % | $ 4.1 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 3.22 | 7.69 % | $ 5.3 M |  Israel |
 |
Liquidia Corporation
LQDA
|
1.53 M | $ 38.39 | 0.62 % | $ 3.3 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
 |
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Aquestive Therapeutics
AQST
|
548 K | $ 4.08 | 0.74 % | $ 436 M | USA |